small molecule

POKONZA

POTASSIUM CHLORIDE

Loss of exclusivityMarch 2039latest FDA-listed patent expiry
CompanyGENUS LIFE SCIENCES INC

Drug detail

Brand namePOKONZA
Active ingredientPOTASSIUM CHLORIDE
Strength10MEQ/15ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2025
Marketing statusRX

Listed patents

PatentExpiresType
12728138March 2039product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.